(0.32%) 5 116.38 points
(0.30%) 38 356 points
(0.37%) 15 987 points
(-0.95%) $83.05
(5.25%) $2.02
(0.29%) $2 354.10
(0.44%) $27.66
(4.16%) $960.50
(-0.26%) $0.932
(-0.45%) $10.98
(-0.57%) $0.796
(1.63%) $93.37
Live Chart Being Loaded With Signals
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies...
Stats | |
---|---|
本日の出来高 | 2 133.00 |
平均出来高 | 80 998.00 |
時価総額 | 5.96M |
EPS | $0 ( 2024-04-04 ) |
次の収益日 | ( $0.0100 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.100 |
ATR14 | $0.0200 (2.67%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Xu Xiaochun | Buy | 4 113 158 | Common Stock |
2024-03-15 | Xu Xiaochun | Sell | 0 | Amendment 4 to 1st Amended & Restated Revolving Credit Agr. |
2023-11-17 | Xu Xiaochun | Sell | 600 000 | Common Stock |
2023-09-28 | Xu Xiaochun | Buy | 654 206 | Common Stock |
2023-09-28 | Xu Xiaochun | Sell | 0 | Amendment 3 to 1st Amended & Restated Revolving Credit Agr. |
INSIDER POWER |
---|
80.48 |
Last 97 transactions |
Buy: 26 026 445 | Sell: 10 013 519 |
Thermogenesis Holdings 相関
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Thermogenesis Holdings 財務諸表
Annual | 2023 |
収益: | $9.45M |
総利益: | $1.93M (20.44 %) |
EPS: | $-7.59 |
FY | 2023 |
収益: | $9.45M |
総利益: | $1.93M (20.44 %) |
EPS: | $-7.59 |
FY | 2022 |
収益: | $10.48M |
総利益: | $2.71M (25.85 %) |
EPS: | $-20.45 |
FY | 2021 |
収益: | $9.29M |
総利益: | $3.49M (37.58 %) |
EPS: | $-43.41 |
Financial Reports:
No articles found.
Thermogenesis Holdings
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。